STEMPOINT CAPITAL LP
NEW YORK, NY · CIK 1952142 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2022 · limited partnership
- Assets managed$761.3m
- Staff7 · 4 in investment roles
- Main clients (by assets)Private funds 85%, Companies 15%
- Private funds2 (2 hedge) · $584.4m gross assets
- Websitestempointcapital.com
- Form ADV · 2026-03-30SEC adviser record
- Legal entitySTEMPOINT CAPITAL LP (US)
$577.9m
reported value
-44.0% vs Q1 2026
73positions
41.2%in top 10
25 new
7 added
41 reduced
22 sold out
vs Q1 2026
Options: 5 call positions ($1.9m notional), 6 put positions ($747.5k notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| TANGO THERAPEUTICS INC TNGX | $38.2m6.62% | Added +821.2k |
| ABIVAX SA ABVX | $37.8m6.54% | Reduced -343.9k |
| REVOLUTION MEDICINES INC RVMD | $30.0m5.18% | Reduced -403.3k |
| ERASCA INC ERAS | $28.7m4.96% | Added +1.1m |
| TYRA BIOSCIENCES INC TYRA | $20.2m3.50% | Added +246.4k |
| DIANTHUS THERAPEUTICS INC DNTH | $19.6m3.39% | Added +29.8k |
| ENLIVEN THERAPEUTICS INC ELVN | $17.6m3.05% | Reduced -380.0k |
| MINERALYS THERAPEUTICS INC MLYS | $16.3m2.81% | Reduced -464.1k |
| BIOHAVEN LTD BHVN | $15.8m2.74% | Reduced -2.1m |
| SURROZEN INC SRZN | $13.8m2.39% | Reduced -118.8k |
| KINIKSA PHARMACEUTICALS INTL KNSA | $13.4m2.32% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $13.2m2.28% | Reduced -1.8m |
| ALKERMES PLC ALKS | $13.0m2.25% | Added +87.0k |
| FIRST TRACKS BIOTHERAPEUTICS TRAX | $12.5m2.17% | New |
| PRAXIS PRECISION MEDICINES I PRAX | $12.5m2.16% | Reduced -75.3k |
| ROIVANT SCIENCES LTD ROIV | $12.3m2.13% | Reduced -423.2k |
| BIOAGE LABS INC BIOA | $11.4m1.97% | Reduced -213.1k |
| CG ONCOLOGY INC CGON | $11.3m1.96% | Reduced -251.9k |
| ORUKA THERAPEUTICS INC ORKA | $11.1m1.92% | New |
| IMMUNOVANT INC IMVT | $10.7m1.84% | Reduced -1.2m |
| CELCUITY INC CELC | $10.3m1.78% | Reduced -21.9k |
| RELMADA THERAPEUTICS INC RLMD | $10.1m1.75% | Added +265.3k |
| CLIMB BIO INC CLYM | $9.7m1.68% | New |
| SPYRE THERAPEUTICS INC SYRE | $9.5m1.64% | Reduced -228.3k |
| ZURA BIO LTD ZURA | $8.1m1.40% | Reduced -138.8k |
| INFLARX NV IFRX | $7.2m1.25% | New |
| AMYLYX PHARMACEUTICALS INC AMLX | $6.9m1.19% | Reduced -955.1k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $6.6m1.15% | Reduced -330.1k |
| OVID THERAPEUTICS INC OVID | $6.5m1.13% | New |
| EQUILLIUM INC EQ | $6.5m1.12% | New |
| DEFINIUM THERAPEUTICS INC DFTX | $6.5m1.12% | Reduced -513.8k |
| CYTOKINETICS INC CYTK | $6.4m1.11% | Reduced -183.6k |
| DAMORA THERAPEUTICS INC COM NEW | $5.6m0.97% | New |
| INVENTIVA SA IVA | $5.4m0.93% | New |
| CENTURY THERAPEUTICS INC IPSC | $5.3m0.91% | New |
| AURA BIOSCIENCES INC AURA | $5.1m0.88% | New |
| EYEPOINT PHARMACEUTICALS INC EYPT | $4.8m0.84% | Reduced -1.3m |
| ASSEMBLY BIOSCIENCES INC ASMB | $4.7m0.81% | Reduced -200.5k |
| AADI BIOSCIENCE INC WHWK | $4.7m0.81% | Reduced -857.7k |
| XENON PHARMACEUTICALS INC XENE | $4.6m0.79% | Reduced -205.4k |
| UNIQURE NV QURE | $4.1m0.70% | Reduced -68.0k |
| COMPASS PATHWAYS PLC CMPS | $4.0m0.70% | New |
| AVALYN PHARMACEUTICALS INC AVLN | $3.9m0.67% | New |
| MAPLIGHT THERAPEUTICS INC MPLT | $3.8m0.66% | Reduced -93.1k |
| ALUMIS INC ALMS | $3.8m0.66% | Reduced -323.4k |
| AXSOME THERAPEUTICS INC AXSM | $3.8m0.65% | New |
| MONTE ROSA THERAPEUTICS INC GLUE | $3.7m0.64% | New |
| ACADIA PHARMACEUTICALS INC ACAD | $3.6m0.63% | Reduced -342.0k |
| SOLID BIOSCIENCES INC SLDB | $3.6m0.62% | Reduced -32.0k |
| PERSONALIS INC PSNL | $3.3m0.57% | New |
| CRESCENT BIOPHARMA INC. CBIO | $3.3m0.57% | New |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $3.2m0.55% | New |
| KODIAK SCIENCES INC KOD | $3.0m0.51% | New |
| PHARVARIS N V PHVS | $2.8m0.48% | Reduced -92.4k |
| MONOPAR THERAPEUTICS INC MNPR | $2.8m0.48% | New |
| RAPPORT THERAPEUTICS INC RAPP | $2.8m0.48% | New |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $2.6m0.46% | Reduced -283.7k |
| SIONNA THERAPEUTICS INC SION | $2.6m0.45% | Reduced -13.7k |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $2.6m0.45% | Reduced -728.6k |
| C4 THERAPEUTICS INC CCCC | $2.4m0.42% | Reduced -382.8k |
| SPRUCE BIOSCIENCES INC SPRB | $2.2m0.39% | Added +28.7k |
| CUE BIOPHARMA INC CUE | $2.1m0.37% | New |
| STRUCTURE THERAPEUTICS INC GPCR | $2.0m0.35% | Reduced -362.4k |
| PROTAGONIST THERAPEUTICS INC PTGX | $2.0m0.35% | Reduced -128.9k |
| HELIX ACQUISITION CORP III HLXC | $1.8m0.32% | Reduced -438.4k |
| BIODESIX INC BDSX | $1.6m0.27% | Reduced -70.0k |
| TENAX THERAPEUTICS INC TENX | $1.4m0.24% | Reduced -281.1k |
| SAB BIOTHERAPEUTICS INC SABS | $1.3m0.23% | Reduced -407.4k |
| CALCIMEDICA INC COM NEW | $1.2m0.21% | New |
| LB PHARMACEUTICALS INC LBRX | $1.0m0.18% | Reduced -68.2k |
| CELLECTAR BIOSCIENCES INC CLRB | $986.7k0.17% | New |
| PROQR THRAPEUTICS N V PRQR | $801.8k0.14% | New |
| VISTAGEN THERAPEUTICS INC VTGN | $17.3k0.00% | Reduced -616.7k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| SYNDAX PHARMACEUTICALS INC SNDX | $56.8m2.4m shares |
| MBX BIOSCIENCES INC MBX | $29.8m998.9k shares |
| DYNE THERAPEUTICS INC DYN | $18.4m1.0m shares |
| EDGEWISE THERAPEUTICS INC EWTX | $18.3m581.7k shares |
| DENALI THERAPEUTICS INC DNLI | $16.4m853.1k shares |
| NURIX THERAPEUTICS INC NRIX | $9.8m630.5k shares |
| EVOMMUNE INC EVMN | $8.8m387.6k shares |
| FAETH THERAPEUTICS INC FTH | $8.4m265.7k shares |
| JOHNSON & JOHNSON JNJ | $7.5m30.8k shares |
| X4 PHARMACEUTICALS INC XFOR | $7.0m1.7m shares |
| VAXCYTE INC PCVX | $6.9m118.1k shares |
| INVIVYD INC IVVD | $4.9m3.7m shares |
| JADE BIOSCIENCES INC JBIO | $4.3m308.1k shares |
| TWIST BIOSCIENCE CORP TWST | $4.1m86.2k shares |
| AVALO THERAPEUTICS INC AVTX | $4.0m269.5k shares |
| IONIS PHARMACEUTICALS INC IONS | $4.0m52.8k shares |
| IMMUNOCORE HLDGS PLC IMCR | $3.8m127.1k shares |
| FORTE BIOSCIENCES INC FBRX | $3.0m116.0k shares |
| LIPOCINE INC NEW LPCN | $2.6m320.8k shares |
| EDWARDS LIFESCIENCES CORP EW | $2.3m29.2k shares |
| CAPRICOR THERAPEUTICS INC CAPR | $2.3m75.2k shares |
| SUTRO BIOPHARMA INC STRO | $1.2m46.6k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| PERSONALIS INC PSNL · Call | $810.8k470.0k shares | New |
| BIOHAVEN LTD BHVN · Call | $525.0k500.0k shares | New |
| SPDR SER TR XBI · Put | $400.0k250.0k shares | New |
| ASTRAZENECA PLC AZN · Call | $180.0k25.0k shares | New |
| SPDR SER TR XBI · Call | $178.0k400.0k shares | Added |
| TANGO THERAPEUTICS INC TNGX · Call | $175.0k100.0k shares | New |
| REVOLUTION MEDICINES INC RVMD · Put | $127.5k30.0k shares | Reduced |
| ERASCA INC ERAS · Put | $90.0k200.0k shares | New |
| ARK ETF TR ARKG · Put | $75.0k100.0k shares | New |
| ROIVANT SCIENCES LTD ROIV · Put | $40.0k100.0k shares | New |
| AMGEN INC AMGN · Put | $15.0k15.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-08-14 | 9.9%≈ $2.4m |
| XILIO THERAPEUTICS INC XLO · 13G · filed 2026-08-14 | 9.5%≈ $5.8m |
| XILIO THERAPEUTICS INC 13G · filed 2026-02-17 | 8.4% |
| SURROZEN INC SRZN · 13G · filed 2026-08-14 | 5.0%≈ $15.6m |